Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MDM2 | Q00987 | 6/20 | 0.51 |
| ▸ | TLR2 | O60603 | 4/20 | 0.50 |
| ▸ | MDM4 | O15151 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29432853 | 1.00 | KMT2A (0.54) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL30674398 | 1.00 | KMT2A (0.54) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL29154138 | 1.00 | KMT2A (0.54) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL29875729 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL29514568 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL26093325 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL120403 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL29401239 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL15521165 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 | |
| SCHEMBL18237098 | 0.97 | KMT2A (0.53) | KMT2AMDM2TLR2MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478708-A | Solid phase synthesis method of ganirelix fragment | 南京汉欣医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113929751-B | Preparation method of ganirelix acetate | 深圳翰宇药业股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-113929751-B | Preparation method of ganirelix acetate | 深圳翰宇药业股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-117285600-A | Synthesis method of ganirelix acetate | 翰宇药业（武汉）有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-114478708-B | Fragment solid-phase synthesis method of ganirelix | 南京汉欣医药科技有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-114478708-A | Solid phase synthesis method of ganirelix fragment | 南京汉欣医药科技有限公司 | 2022-05-13 | — | — | CN | disclosed |